MBA, Cranfield School of Management, Cranfield

PhD in Organic Chemistry, University of York, York

BSc (Hons) Chemistry, University of East Anglia, Norwich

MBA, International Institute for Management Development (IMD)

BA, Economics, Business, German, Wabash College

MSc Business Marketing, Ecole Supérieure des Technologies et des Affaires – ESTA

German qualified lawyer, University of Passau, Passau, Germany

Master of Business Administration and Bachelor of Science – Mechanical Engineering from the University of Sherbrooke in Canada.

DBA degree (ongoing), International Management Institute (IMI-Kyiv)

MBA, International Management Institute (IMI-Kyiv)

PhD in cardiology, Research Institute of Therapy (Academy of Medical Science of Ukraine)

MD, Kharkiv Medical Institute, honors

MBA, Finance, Business Administration and Management Sciences, Imperial College London

BSc (Hons), Computer Science

Ingénieur, Ecole de Purpan, Toulouse

Klyde holds a Master of Science – Physics from the University of Strasbourg and a Master in Project Management

MSc in International Management, Audencia, Nantes

MSc in International Business, Aston University, Birmingham

BBA, Lund University, Lund

MD University of Palacky, CZ

MSc in Regulatory Affairs University of Wales, UK

PhD in Clinical and Social Pharmacy Charles University, CZ

Larisa holds a degree from the University of Oslo, Norway, where she majored in English and marketing communications.

BSc of Management Sciences, Sadat Academy for Management Sciences, MBA, CPIM /APICS

BA degree from Bogazici University in Business Administration

Executive education programs at London Business School and Harvard Business School.

Semih Sen has over 25 years of experience in leading healthcare organisations, business and project development, building start-ups and creating financial solutions for medical and digital technologies on an international scale. He has built and led many healthcare assets as an investor, board member, financier, asset manager and advisor across Europe, Middle East and USA.

MBA (honors), The Wharton School, University of Pennsylvania, USA

BS Electrical Engineering, Grove City College, USA

Milad Hadziabdic is the Head of Mergers & Acquisitions at ADQ. Prior to ADQ, Milad was a Managing Director in Mergers & Acquisitions Investment Banking at Citigroup for over 16 years in both New York and London. At Citigroup, he led M&A advisory efforts for the Healthcare Services sector in the US and for the Industrials sector across EMEA. Prior to Citigroup, Milad spent 7 years at General Electric, in engineering and finance roles, most recently managing finance for a division of GE Transportation Systems.

Corporate Director Certificate from Harvard Business School

Hamda Eid AlMheiri is the Head of Government Affairs at ADQ and a member of Presight’s board of directors . In a prior position at ADQ, Hamda led the Corporate Planning and Performance Department which forms part of the Strategy function. Her professional track record includes roles with the Abu Dhabi Executive Office as a Project Manager in charge of financial policy and efficiency and the General Secretariat of the Executive Council of Abu Dhabi as a Financial Policy and Efficiency Specialist. Previously, Hamda served as Manager Commercial Analyst for Strategy and Planning at Etihad Airways.

Computer science engineer, Minho University, Portugal

General management program, INSEAD, Paris and Singapore.

Executive education programs at IMD business school in Switzerland, Wharton and Harvard business school in the USA.

Isabel Afonso is the CEO of the Life Sciences international platform, owned by ADQ. Prior to this role, Isabel was the Head of In-Market Brands and Business Innovation for Novartis International based in Basel, Switzerland. Before moving to HQ she was the general manager in China for Novartis Oncology, a major focus market for Novartis. Until beginning of 2021, Isabel served as the Chief Commercial Officer at Performance Health. Between 2002 and 2018, she held multiple business and functional leadership roles in the Novartis group.

Executive education, Yale School of Management

Bachelor of Science in Business Administration with a major in Finance, American University of Sharjah

Abdullah Tahlak is an Investment Manager of ADQ’s Healthcare, Life Sciences and Financial Services Portfolio. Prior to joining ADQ, Abdullah served as an investment professional within Mubadala Capital’s Private Equity Team.